| Fiscal Year End | Company Status | Exempt Flag |
| May 31 | Trading | N |
|
|
|
|
|
| Incorporation Locations |
| Inc. Date | Expiry Date | Country | Region | Description |
| 15/Sep/1997 | | Canada | Quebec | |
|
|
| Exchange Filing Office |
| Location |
| Calgary Regional Service Office |
|
|  |
| Business Type(s) |
| Primary/Secondary | Business Type | Details |
| Primary
| Pharmaceutical Manufacturer and Distributor
| Medicure is a specialty pharmaceutical company focused on the development and commercialization of novel small molecule therapeutics. The primary focus of the Company and its subsidiaries is the marketing and distribution of AGGRASTAT? (tirofiban HCl) for acute coronary syndromes in the United States, where it is sold through the Company's US subsidiary, Medicure Pharma, Inc. For more information on Medicure please visit www.medicure.com.
|
|
|
| Securities |
| Symbol | Security Name | Market | Status |
| MPH | Medicure Inc. | TSX Venture | TRADING |
|
|
| Name History | From | To |
| Medicure Inc. | 18/Feb/2010 | Present |
|
|
| Company Facts Reconciliation |
| Subject | Date Returned |
| Spring 2015 CFR | Not Received |
|
|
|
|
|
